Estrogen is important for bone health in men as well as women

DXA scans of a male patient with osteoporosisAlthough women are four times more likely than men to develop osteoporosis, or porous bone, one in 12 men also suffer from the disease, which can lead to debilitating – or even life-threatening – fractures. In women, low estrogen levels after menopause have been considered an important risk factor for this disorder. Now research at Washington University School of Medicine in St. Louis has shown that low amounts of active estrogen metabolites also can increase the the risk of osteoporosis in men.

Study to investigate gene’s effect on bone loss in breast cancer patients

Women with estrogen-responsive breast cancer are often prescribed a drug that reduces their estrogen levels. But because estrogen is important to bone health, there is widespread concern about how the estrogen-reducing drugs – called aromatase inhibitors – affect bones. A study at the School of Medicine will investigate bone loss in women taking aromatase inhibitors, and researchers are calling for interested women to volunteer.

Medical team rebuilds faces ravaged by injury and disease

Gravenhorst’s new ear is repositioned during an office visit to the maxillofacial prosthetics lab.Like any 17-year-old, Emily Gravenhorst follows a routine to get ready for a day of high school. She showers, styles her hair, puts on her make-up and eats breakfast. And just before she leaves the house, she puts on her right ear. That ear was created in the maxillofacial prosthetics laboratory at Washington University School of Medicine in St. Louis, where one dental specialist and one technician help patients fit back into society after disfigurement due to accident or disease.

New clues for treatment of disease that causes accelerated aging

There is renewed hope for treatment of a rare genetic condition that causes rapidly accelerated aging and leads to an average life expectancy of 13 years. Scientists studying the genes of two infants who died of mysterious illnesses found the infants had mutations in LMNA, the same gene altered in patients with the premature aging condition progeria. But the infants’ unusual mutations caused them to make many more bad copies of the gene’s primary protein, lamin A, than progeria patients.

Shaw named Unanue Professor of Immunobiology; will direct new division

Andrey Shaw, M.D., has been named the Emil R. Unanue Professor of Immunobiology in the Department of Pathology and Immunology at the School of Medicine. The announcement will be made by Larry Shapiro, M.D., executive vice chancellor for medical affairs and dean of the School of Medicine, at a symposium in honor of Unanue held on April 27 at the School of Medicine.

Symposium honoring WUSM professor focuses on new immunology discoveries

UnanueImmunology researchers from across the United States and as far away as Sweden are coming to the School of Medicine to discuss some of the latest scientific insights into the immune system. The general public is welcome to attend.The symposium, “Immunology at the Horizon of the New Millennium,” is being held in honor of Emil Unanue, M.D., the Paul and Ellen Lacy Professor of Pathology. Unanue served as head of the Department of Pathology and Immunology for 21 years, stepping down last summer.
Older Stories